 IRVINE, Calif., Jan. 08, 2021 GLOBE NEWSWIRE -- Inari Medical, Inc. NASDAQ: NARI Inari a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced U.S. Food and Drug Administration FDA 510k clearance of the FlowTriever system for the treatment of clot in transit CIT in the right atrium. 